3/10
08:35 am
rnac
Cartesian Therapeutics (RNAC) had its "outperform" rating reaffirmed by Wedbush. They now have a $38.00 price target on the stock.
Medium
Report
Cartesian Therapeutics (RNAC) had its "outperform" rating reaffirmed by Wedbush. They now have a $38.00 price target on the stock.
3/9
06:05 pm
rnac
Cartesian Therapeutics (RNAC) had its "buy" rating reaffirmed by BTIG Research.
Medium
Report
Cartesian Therapeutics (RNAC) had its "buy" rating reaffirmed by BTIG Research.
3/9
12:42 pm
rnac
Cartesian Therapeutics (RNAC) had its "buy" rating reaffirmed by Needham & Company LLC. They now have a $42.00 price target on the stock.
Medium
Report
Cartesian Therapeutics (RNAC) had its "buy" rating reaffirmed by Needham & Company LLC. They now have a $42.00 price target on the stock.
3/9
11:00 am
rnac
Cartesian Therapeutics (RNAC) was upgraded by Cantor Fitzgerald from "neutral" to "overweight". They now have a $16.00 price target on the stock.
High
Report
Cartesian Therapeutics (RNAC) was upgraded by Cantor Fitzgerald from "neutral" to "overweight". They now have a $16.00 price target on the stock.
3/9
07:03 am
rnac
Cartesian Therapeutics Reports Full Year 2025 Financial Results and Provides Business Update [Yahoo! Finance]
High
Report
Cartesian Therapeutics Reports Full Year 2025 Financial Results and Provides Business Update [Yahoo! Finance]
3/9
07:00 am
rnac
Cartesian Therapeutics Reports Full Year 2025 Financial Results and Provides Business Update
High
Report
Cartesian Therapeutics Reports Full Year 2025 Financial Results and Provides Business Update
2/23
07:02 am
rnac
Cartesian Therapeutics to Participate in Upcoming Investor Conferences [Yahoo! Finance]
Low
Report
Cartesian Therapeutics to Participate in Upcoming Investor Conferences [Yahoo! Finance]
2/23
07:00 am
rnac
Cartesian Therapeutics to Participate in Upcoming Investor Conferences
Low
Report
Cartesian Therapeutics to Participate in Upcoming Investor Conferences
3/9/2026
07:00 am
RNAC
cartesian therapeutics, inc.
MISS
Report
32.6%
cartesian therapeutics, inc.
11/6/2025
07:00 am
RNAC
cartesian therapeutics, inc.
MISS
Report
-1.6%
cartesian therapeutics, inc.
3/13
04:15 pm
rnac
Form 4 Cartesian Therapeutics, For: Mar 13 Filed by: Singer Michael
Medium
Report
Form 4 Cartesian Therapeutics, For: Mar 13 Filed by: Singer Michael
3/13
03:55 pm
rnac
Form SCHEDULE 13G Cartesian Therapeutics, Filed by: Squarepoint Ops LLC
Low
Report
Form SCHEDULE 13G Cartesian Therapeutics, Filed by: Squarepoint Ops LLC
3/9
07:06 am
rnac
Form 10-K Cartesian Therapeutics, For: Dec 31
High
Report
Form 10-K Cartesian Therapeutics, For: Dec 31
3/9
07:03 am
rnac
Form 8-K Cartesian Therapeutics, For: Mar 09
High
Report
Form 8-K Cartesian Therapeutics, For: Mar 09
2/5
01:21 pm
rnac
Form SCHEDULE 13G/A Cartesian Therapeutics, Filed by: FMR LLC
Medium
Report
Form SCHEDULE 13G/A Cartesian Therapeutics, Filed by: FMR LLC
1/13
04:04 pm
rnac
Form 144 Cartesian Therapeutics, Filed by: Jewell Christopher M
Low
Report
Form 144 Cartesian Therapeutics, Filed by: Jewell Christopher M
1/9
04:36 pm
rnac
Form 144 Cartesian Therapeutics, Filed by: Jewell Christopher M
High
Report
Form 144 Cartesian Therapeutics, Filed by: Jewell Christopher M
1/9
08:06 am
rnac
Form 8-K Cartesian Therapeutics, For: Jan 09
Medium
Report
Form 8-K Cartesian Therapeutics, For: Jan 09
News Stats
All News
News Wires
Media Monitoring
SEC Edgar Filings
Upgrades
Downgrades
Initiated
Reiterated
Last Earnings
Last Earnings EPS
Next Earnings
Order Stats
Sub-Penny
Odd lot
Avg. bid-ask spread
Avg. bid-ask size
Shares at ask/bid
Off exchange
Main News & Impact Reports
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below:
Register